Clinical Trials for Alimera Sciences

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Alimera Sciences

Clinical Trials (4)

NCT06539481
Open Label Trial Studying the Safety and Effectiveness of ILUVIEN® (190μg) in Children and Adolescents, Who Have Recurrent Non-infectious Uveitis Affecting the Posterior Segment of the Eye.
PHASE4Recruiting
25 participants
Started: Aug 31, 2024 · Completed: Oct 31, 2028
1 condition1 sponsor6 locations
NCT05844982
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
PHASE3Recruiting
600 participants
Started: Nov 21, 2023 · Completed: Dec 26, 2029
2 conditions5 sponsors19 locations
NCT05322070
Fluocinolone Acetonide Intravitreal Implant 0.18 mg in the Treatment of Chronic Non-Infectious Posterior Segment Uveitis
PHASE4Active, not recruiting
125 participants
Started: Jun 6, 2022 · Completed: Nov 30, 2025
1 condition2 sponsors23 locations
NCT04469595
A Study of Intravitreal ILUVIEN® Implant as Baseline Therapy in Patients With Early Diabetic Macular Edema (DME)
PHASE4Active, not recruiting
300 participants
Started: Aug 31, 2020 · Completed: Dec 31, 2024
1 condition1 sponsor40 locations